Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | 70710-1062 | 70710-1062-0170710-1062-05 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70710-1643 | 70710-1643-07 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70710-1644 | 70710-1644-05 | — |
| dimethyl fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 70710-1204 | 70710-1204-07 | — |
| dimethyl fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 70710-1205 | 70710-1205-0670710-1205-08 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 68382-737 | 68382-0737-01 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 68382-738 | 68382-0738-01 | — |
| Midodrine hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 68382-739 | 68382-0739-01 | — |
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 68382-824 | 68382-0824-1068382-0824-2768382-0824-77 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 70710-1530 | 70710-1530-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 70710-1531 | 70710-1531-01 | — |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | 68382-591 | 68382-0591-0168382-0591-0568382-0591-30 | — |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | 68382-592 | 68382-0592-0168382-0592-0568382-0592-30 | — |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | 68382-593 | 68382-0593-0168382-0593-0568382-0593-30 | — |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | 68382-594 | 68382-0594-0168382-0594-0568382-0594-30 | — |
| deferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | 70710-1276 | 70710-1276-0170710-1276-03 | — |
| Lamotrigine | Lamotrigine 25 mg/1 | Tablet, Extended releaseOral | 68382-979 | 68382-0979-0568382-0979-0668382-0979-16 | — |
| Lamotrigine | Lamotrigine 50 mg/1 | Tablet, Extended releaseOral | 68382-980 | 68382-0980-0568382-0980-0668382-0980-16 | — |
| Lamotrigine | Lamotrigine 100 mg/1 | Tablet, Extended releaseOral | 68382-981 | 68382-0981-0568382-0981-0668382-0981-16 | — |
| Lamotrigine | Lamotrigine 200 mg/1 | Tablet, Extended releaseOral | 68382-982 | 68382-0982-0568382-0982-0668382-0982-16 | — |
| Lamotrigine | Lamotrigine 250 mg/1 | Tablet, Extended releaseOral | 68382-983 | 68382-0983-0568382-0983-0668382-0983-16 | — |
| Lamotrigine | Lamotrigine 300 mg/1 | Tablet, Extended releaseOral | 68382-984 | 68382-0984-0568382-0984-0668382-0984-16 | — |
| Baclofen | Baclofen 5 mg/1 | TabletOral | 70710-1609 | 70710-1609-01 | — |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | TabletOral | 68382-913 | 68382-0913-0668382-0913-1668382-0913-84 | — |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | TabletOral | 68382-914 | 68382-0914-0668382-0914-1668382-0914-84 | — |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | TabletOral | 68382-915 | 68382-0915-0668382-0915-1668382-0915-84 | — |
| Mesalamine | Mesalamine 1000 mg/1 | SuppositoryRectal | 70710-1302 | 70710-1302-07 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | 70710-1532 | 70710-1532-06 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | 70710-1534 | 70710-1534-06 | — |
| Chlorpromazine hydrochloride | Chlorpromazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 70710-1129 | 70710-1129-0170710-1129-04 | — |
| Chlorpromazine hydrochloride | Chlorpromazine hydrochloride 25 mg/1 | Tablet, Film coatedOral | 70710-1130 | 70710-1130-0170710-1130-04 | — |
| Chlorpromazine hydrochloride | Chlorpromazine hydrochloride 50 mg/1 | Tablet, Film coatedOral | 70710-1131 | 70710-1131-0170710-1131-04 | — |
| Chlorpromazine hydrochloride | Chlorpromazine hydrochloride 100 mg/1 | Tablet, Film coatedOral | 70710-1132 | 70710-1132-0170710-1132-04 | — |
| Chlorpromazine hydrochloride | Chlorpromazine hydrochloride 200 mg/1 | Tablet, Film coatedOral | 70710-1133 | 70710-1133-0170710-1133-04 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 5 mg/1 | TabletOral | 70710-1148 | 70710-1148-0070710-1148-01 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 10 mg/1 | TabletOral | 70710-1149 | 70710-1149-0070710-1149-01 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 20 mg/1 | TabletOral | 70710-1150 | 70710-1150-0070710-1150-01 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 30 mg/1 | TabletOral | 70710-1151 | 70710-1151-0070710-1151-01 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 40 mg/1 | TabletOral | 70710-1152 | 70710-1152-01 | — |
| deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | 70710-1275 | 70710-1275-0170710-1275-03 | — |
| deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | 70710-1277 | 70710-1277-0170710-1277-03 | — |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 70710-1461 | 70710-1461-0670710-1461-09 | — |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 70710-1462 | 70710-1462-0170710-1462-05 | — |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 70710-1463 | 70710-1463-0170710-1463-05 | — |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 70710-1464 | 70710-1464-0170710-1464-05 | — |
| Colesevelam | Colesevelam hydrochloride 625 mg/1 | Tablet, Film coatedOral | 68382-619 | 68382-0619-1068382-0619-2868382-0619-77 | — |
| Arsenic trioxide | Arsenic trioxide 2 mg/mL | Injection, SolutionIntravenous | 70710-1610 | 70710-1610-06 | — |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | 70710-1344 | 70710-1344-0170710-1344-0370710-1344-05 | — |
| potassium chloride | Potassium chloride 600 mg/1 | Capsule, Extended releaseOral | 68382-853 | 68382-0853-0168382-0853-0568382-0853-10+1 more | — |
| potassium chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | 68382-854 | 68382-0854-0168382-0854-0568382-0854-10+1 more | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.